Interestingly, ameliorating the desmin-associated defects in these cardiomyocytes provided cardioprotection from the H222P lamin A/C mutation (Galata et al., 2018), suggesting that desmin is a promising target for certain laminopathies. The gene discussed is DES; the disease is laminopathy.